Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) issued a Next Day Disclosure Return dated 29 January 2026, highlighting adjustments to its issued shares and treasury shares resulting from a repurchase of A shares.

On 29 January 2026, 371,600 A shares were repurchased for the A Share Employee Stock Ownership Schemes at prices ranging from RMB 56.10 to RMB 58.07, with an aggregate payment of approximately RMB 21.07 million. Following this transaction, the number of issued shares excluding treasury shares stands at 6,374,716,724. Treasury shares increased to 4,285,550, and the total issued shares remain 6,379,002,274.

The announcement confirms compliance with relevant regulatory and legal requirements. No additional share redemptions or cancellations were reported. The disclosed figures reflect the company’s updated share structure as of the closing balance on 29 January 2026.